Free fatty acids cannot penetrate any biological membrane due to their negative charge. Free fatty acids must cross the cell membrane through specifictransport proteins, such as theSLC27 family fatty acid transport protein.[1] Once in thecytosol, the following processes bring fatty acids into the mitochondrial matrix so that beta-oxidation can take place.
Acyl-carnitine is converted back to acyl-CoA bycarnitine palmitoyltransferase II, located on the interior face of theinner mitochondrial membrane. The liberated carnitine is shuttled back to the cytosol, as an acyl-carnitine is shuttled into the matrix.
If the fatty acyl-CoA contains a short chain, theseshort-chain fatty acids can simply diffuse through the inner mitochondrial membrane.
Step 1
Step 2
Step 3
Step 4
A diagrammatic illustration of the process of lipolysis (in a fat cell) induced by highepinephrine and lowinsulin levels in the blood. Epinephrine binds to abeta-adrenergic receptor in the cell wall of the adipocyte, which causescAMP to be generated inside the cell. The cAMP activates aprotein kinase, which phosphorylates and activates ahormone-sensitive lipase in the fat cell. This lipase cleaves free fatty acids from their attachment to glycerol in the adipocyte. The free fatty acids and glycerol are then released into the blood.
A diagrammatic illustration of the transport offree fatty acids in the blood attached toplasma albumin, its diffusion across the cell membrane using a protein transporter, and its activation, usingATP, to formacyl-CoA in thecytosol. The illustration is of a 12 carbon fatty acid.
A diagrammatic illustration of the transfer of an acyl-CoA molecule across the inner membrane of themitochondrion bycarnitine-acyl-CoA transferase (CAT). The illustrated acyl chain is 12 carbon atoms long. CAT is inhibited by high concentrations ofmalonyl-CoA (the first committed step infatty acid synthesis) in the cytoplasm. This means that fatty acid synthesis and fatty acid catabolism cannot occur simultaneously in any given cell.
A diagrammatic illustration of the process of thebeta-oxidation of an acyl-CoA molecule in the mitochondrial matrix. During this process an acyl-CoA molecule which is 2 carbons shorter than it was at the beginning of the process is formed. Acetyl-CoA, water and 5ATP molecules are the other products of each beta-oxidative event, until the entire acyl-CoA molecule has been reduced to a set ofacetyl-CoA molecules.
Once the fatty acid is inside themitochondrial matrix, beta-oxidation occurs by cleaving two carbons every cycle to form acetyl-CoA. The process consists of 4 steps.[2]
A long-chain fatty acid isdehydrogenated to create a transdouble bond between C2 and C3. This is catalyzed byacyl CoA dehydrogenase to produce trans-delta 2-enoyl CoA. It uses FAD as an electron acceptor and it is reduced to FADH2.
Trans-delta 2-enoyl CoA is hydrated at the double bond to produce L-3-hydroxyacyl CoA byenoyl-CoA hydratase.
L-3-hydroxyacyl CoA is dehydrogenated again to create 3-ketoacyl CoA by 3-hydroxyacyl CoA dehydrogenase. This enzyme uses NAD as an electron acceptor.
Thiolysis occurs between C2 and C3 (alpha and beta carbons) of 3-ketoacyl CoA. Thiolase enzyme catalyzes the reaction when a new molecule of coenzyme A breaks the bond by nucleophilic attack on C3. This releases the first two carbon units, as acetyl CoA, and a fatty acyl CoA minus two carbons. The process continues until all of the carbons in the fatty acid are turned into acetyl CoA.
This acetyl-CoA then enters the mitochondrial tricarboxylic acid cycle (TCA cycle). Both the fatty acid beta-oxidation and the TCA cycle produce NADH and FADH2, which are used by the electron transport chain to generate ATP.
Fatty acids are oxidized by most of the tissues in the body. However, some tissues such as thered blood cells of mammals (which do not contain mitochondria) and cells of thecentral nervous system do not use fatty acids for their energy requirements, but instead use carbohydrates (red blood cells and neurons) orketone bodies (neurons only).
Because many fatty acids are not fully saturated or do not have an even number of carbons, several different mechanisms have evolved, described below.
Once inside the mitochondria, each cycle of β-oxidation, liberating a two carbon unit (acetyl-CoA), occurs in a sequence of four reactions:[3]
Description
Diagram
Enzyme
End product
Dehydrogenation byFAD: The first step is the oxidation of the fatty acid by Acyl-CoA-Dehydrogenase. The enzyme catalyzes the formation of a trans-double bond between the C-2 and C-3 by selectively remove hydrogen atoms from the β-carbon. The regioselectivity of this step is essential for the subsequent hydration and oxidation reactions.
Hydration: The next step is thehydration of the bond between C-2 and C-3. The reaction isstereospecific, forming only the Lisomer. Hydroxyl group is positioned suitable for the subsequent oxidation reaction by 3-hydroxyacyl-CoA dehydrogenase to create a β-keto group.
Thiolysis: The final step is the cleavage of β-ketoacyl CoA by thethiol group of another molecule ofCoenzyme A. The thiol is inserted between C-2 and C-3.
Anacetyl-CoA molecule, and anacyl-CoA molecule that is two carbons shorter
This process continues until the entire chain is cleaved into acetyl CoA units. The final cycle produces two separate acetyl CoAs, instead of one acyl CoA and one acetyl CoA. For every cycle, the Acyl CoA unit is shortened by two carbon atoms. Concomitantly, one molecule of FADH2, NADH and acetyl CoA are formed.
The beta-Oxidation cycle pathway diagram illustrates the metabolic reactions that allow for the breakdown of fatty acids into NADH and ATP, often taught in connection with the electron transport chain and ATP synthase. This is an example of "even-numbered" saturated fatty acid metabolism
Propionyl-CoA modification after beta oxidation of odd-chain fatty acid
Fatty acids with an odd number of carbons are found in the lipids of plants and some marine organisms. Many ruminant animals form a large amount of 3-carbon propionate during the fermentation of carbohydrates in the rumen.[4] Long-chain fatty acids with an odd number of carbon atoms are found particularly in ruminant fat and milk.[5]
Chains with an odd-number ofcarbons are oxidized in the same manner as even-numbered chains, but the final products arepropionyl-CoA and acetyl-CoA.
However, whereas acetyl-CoA enters the citric acid cycle by condensing with an existing molecule ofoxaloacetate, succinyl-CoA enters the cycle as a principal in its own right. Thus, the succinate just adds to the population of circulating molecules in the cycle and undergoes no net metabolization while in it. When this infusion of citric acid cycle intermediates exceedscataplerotic demand (such as foraspartate orglutamate synthesis), some of them can be extracted to thegluconeogenesis pathway, in the liver and kidneys, throughphosphoenolpyruvate carboxykinase, and converted to free glucose.[7]
β-Oxidation of unsaturated fatty acids poses a problem since the location of a cis-bond can prevent the formation of a trans-Δ2 bond which is essential for continuation of β-Oxidation as this conformation is ideal for enzyme catalysis. This is handled by additional two enzymes,Enoyl CoA isomerase and2,4 Dienoyl CoA reductase.[8]
β-oxidation occurs normally until the acyl CoA (because of the presence of a double bond) is not an appropriate substrate foracyl CoA dehydrogenase, orenoyl CoA hydratase:
If the acyl CoA contains acis-Δ3 bond, thencis-Δ3-Enoyl CoA isomerase will convert the bond to atrans-Δ2 bond, which is a regular substrate.
If the acyl CoA contains acis-Δ4 double bond, then its dehydrogenation yields a 2,4-dienoyl intermediate, which is not a substrate for enoyl CoA hydratase. However, the enzyme2,4 Dienoyl CoA reductase reduces the intermediate, using NADPH, intotrans-Δ3-enoyl CoA. This compound is converted into a suitable intermediate by 3,2-Enoyl CoA isomerase and β-Oxidation continues.
Fatty acid oxidation also occurs inperoxisomes when the fatty acid chains are too long to be processed by the mitochondria. The same enzymes are used in peroxisomes as in the mitochondrial matrix and acetyl-CoA is generated. Very long chain (greater than C-22) fatty acids, branched fatty acids,[9] someprostaglandins andleukotrienes[10] undergo initial oxidation in peroxisomes untiloctanoyl-CoA is formed, at which point it undergoes mitochondrial oxidation.[11]
Peroxisomal β-oxidation also requires enzymes specific to the peroxisome and to very long fatty acids. There are four key differences between the enzymes used for mitochondrial and peroxisomal β-oxidation:
The NADH formed in the third oxidative step cannot be reoxidized in the peroxisome, so reducing equivalents are exported to the cytosol.
β-oxidation in the peroxisome requires the use of a peroxisomalcarnitine acyltransferase (instead of carnitine acyltransferase I and II used by the mitochondria) for transport of the activated acyl group into the mitochondria for further breakdown.
The first oxidation step in the peroxisome is catalyzed by the enzymeacyl-CoA oxidase.
Theβ-ketothiolase used in peroxisomal β-oxidation has an altered substrate specificity, different from the mitochondrialβ-ketothiolase.
Peroxisomal oxidation is induced by a high-fat diet and administration of hypolipidemic drugs likeclofibrate.
Theoretically, the ATP yield for each oxidation cycle where two carbons are broken down at a time is 17, as each NADH produces 3 ATP, FADH2 produces 2 ATP and a full rotation of Acetyl-CoA in citric acid cycle produces 12 ATP.[13] In practice, it is closer to 14 ATP for a full oxidation cycle as 2.5 ATP per NADH molecule is produced, 1.5 ATP per each FADH2 molecule is produced and Acetyl-CoA produces 10 ATP per rotation of the citric acid cycle[13](according to theP/O ratio). This breakdown is as follows:
For an even-numbered saturated fat (Cn), 0.5 * n - 1 oxidations are necessary, and the final process yields an additional acetyl CoA. In addition, two equivalents ofATP are lost during the activation of the fatty acid. Therefore, the total ATP yield can be stated as:
Steps in beta-oxidation of odd-numbered saturated fatty acids[15]
For an odd-numbered saturated fat (Cn), 0.5 * n - 1.5 oxidations are necessary, and the final process yields 8 acetyl CoA and 1 propionyl CoA. It is then converted to a succinyl CoA by a carboxylation reaction and generates additional 5 ATP (1 ATP is consumed in carboxylation process generating a net of 4 ATP). In addition, two equivalents ofATP are lost during the activation of the fatty acid. Therefore, the total ATP yield can be stated as:
There are at least 25 enzymes and specific transport proteins in the β-oxidation pathway.[16] Of these, 18 have been associated with human disease asinborn errors of metabolism.
Furthermore, studies indicate that lipid disorders are involved in diverse aspects of tumorigenesis, and fatty acid metabolism makes malignant cells more resistant to a hypoxic environment. Accordingly, cancer cells can display irregular lipid metabolism with regard to both fatty acid synthesis and mitochondrialfatty acid oxidation (FAO) that are involved in diverse aspects of tumorigenesis and cell growth.[17] Several specific β-oxidation disorders have been identified.
Medium-chain acyl-coenzyme A dehydrogenase (MCAD) deficiency
Medium-chain acyl-coenzyme A dehydrogenase (MCAD) deficiency[18] is the most common fatty acid β-oxidation disorder and a prevalent metabolic congenital error It is often identified through newborn screening. Although children are normal at birth, symptoms usually emerge between three months and two years of age, with some cases appearing in adulthood.
Medium-chain acyl-CoA dehydrogenase (MCAD) plays a crucial role in mitochondrial fatty acid β-oxidation, a process vital for generating energy during extended fasting or high-energy demand periods. This process, especially important when liver glycogen is depleted, supports hepatic ketogenesis. The specific step catalyzed by MCAD involves the dehydrogenation of acyl-CoA. This step converts medium-chain acyl-CoA to trans-2-enoyl-CoA, which is then further metabolized to produce energy in the form of ATP.
Symptoms
Affected children, who seem healthy initially, may experience symptoms like low blood sugar without ketones (hypoketotic hypoglycemia) andvomiting
Long-chain hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency[19] is a mitochondrial effect of impaired enzyme function.
LCHAD performs the dehydrogenation of hydroxyacyl-CoA derivatives, facilitating the removal of hydrogen and the formation of aketo group. This reaction is essential for the subsequent steps in beta oxidation that lead to the production of acetyl-CoA, NADH, and FADH2, which are important for generating ATP, the energy currency of the cell.
Long-chain hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency is a condition that affects mitochondrial function due to enzyme impairments. LCHAD deficiency is specifically caused by a shortfall in the enzymelong-chain 3-hydroxyacyl-CoA dehydrogenase. This leads to the body's inability to transform specific fats into energy, especially during fasting periods.
Very long-chain acyl-coenzyme A dehydrogenase deficiency (VLCAD deficiency) is a genetic disorder that affects the body's ability to break down certain fats. In the β-oxidation cycle, VLCAD's role involves the removal of two hydrogen atoms from the acyl-CoA molecule, forming a double bond and converting it into trans-2-enoyl-CoA. This crucial first step in the cycle is essential for the fatty acid to undergo further processing and energy production. When there is a deficiency in VLCAD, the body struggles to effectively break down long-chain fatty acids. This can lead to a buildup of these fats and a shortage of energy, particularly during periods of fasting or increased physical activity.[20]
^abcdRodwell, Victor (2015).Harper's illustrated Biochemistry, 30th edition. USA: McGraw Hill Education. p. 164.ISBN978-0-07-182537-5.
^Jain P, Singh S, Arya A (January 2021). "A student centric method for calculation of fatty acid energetics: Integrated formula and web tool".Biochemistry and Molecular Biology Education.1 (1):492–499.doi:10.1002/bmb.21486.PMID33427394.S2CID231577993.
^Ezzeddini R, Taghikhani M, Salek Farrokhi A, Somi MH, Samadi N, Esfahani A, Rasaee, MJ (May 2021). "Downregulation of fatty acid oxidation by involvement of HIF-1α and PPARγ in human gastric adenocarcinoma and its related clinical significance".Journal of Physiology and Biochemistry.77 (2):249–260.doi:10.1007/s13105-021-00791-3.PMID33730333.S2CID232300877.